sacituzumab
gilead sciences
['breast', 'tropics02']
updated results from the phase 3 #tropics02 trial show positive results for patients with hr+/her2- #breastcancer. #esmo22 
OBR is an oncology-focused digital media company that provides news and information resources to oncology professionals.